JPRN-jRCT2080222365未知2 期
KD-FLU Phase II Study in healthy Adults clinical trial
试验速览
- 阶段
- 2 期
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 64age old（—）
- 性别
- All
入选标准
- •(1) Subjects who are healthy adults aged between 20 inclusive and 65 exclusive at the time of obtaining informed consent.
- •(2) Subjects who are able to give written informed consent.
排除标准
- 未提供
研究者
相似试验
未知
2 期
BK-FLU Phase II Study in healthy Adults clinical trialJPRN-jRCT2080222459The Research Foundation for Microbial Diseases of Osaka University55
未知
2 期
Clinical trial of KD-FLU in healthy childreProphylaxis of influenza infectionJPRN-jRCT2080221413The Chemo-Sero-Therapeutic Research Institute40
招募中
1 期
Randomized Phase 2 Study of DKN-01 Plus FOLFIRI/FOLFOX and Bevacizumab Versus FOLFIRI/FOLFOX and Bevacizumab as Second-line Treatment of Advanced Colorectal Cancer (DeFianCe)Colorectal CancerCTIS2022-501465-40-00eap Therapeutics Inc.156
已完成
2 期
Phase 2 Study of DKN-01 in Colorectal CancerColorectal AdenocarcinomaColo-rectal CancerColorectal Cancer MetastaticColorectal CancerNCT05480306Leap Therapeutics, Inc.188
进行中（未招募）
不适用
Multicentric Pilot Phase II Study for use of Fludarabine plus Cyclophosphamide Followed by 90 Y-Ibritumomab Tiuxetan Zevalin in the Treatment of non-Follicular Indolent Lymphomas Refractory or Relapsed after Conventional Front-Line Chemotherapy not Containing FludarabineTreatment patients with non-Follicular Indolent Lymphomas Refractory or Relapsed after Conventional Front-Line Chemotherapy not Containing Fludarabine and CiclofosfamideEUCTR2005-000699-41-ITAZIENDA OSPEDALIERA OSPEDALI RIUNITI DI BERGAMO A.O. DI RILIEVO NAZIONALE80